MicroRNAs in metabolic effects with atypical antipsychotics-a scoping review
{{output}}
Background: Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroR... ...
